E <b>F</b> fects of Y-6 S <b>U</b> blingual Tablets for Pa <b>T</b> ients with Ac <b>U</b> te Ischemic St <b>R</b> ok <b>E</b> (FUTURE): a phase II, randomised, double-blind, double-dummy, placebo-controlled, parallel trial

Authors

Y. Wang (ORCID: https://orcid.org/0000-0002-0271-626X)
Xiaoling Liao (ORCID: https://orcid.org/0000-0003-4620-9224)
Xiaochuan Huo (ORCID: https://orcid.org/0000-0003-1264-5132)
Yuesong Pan (ORCID: https://orcid.org/0000-0003-3082-6789)
Zixiao Li (ORCID: https://orcid.org/0000-0002-4713-5418)
Baoshan Qiu (ORCID: https://orcid.org/0000-0002-9194-2532)
Liping Liu (ORCID: https://orcid.org/0000-0003-2943-055X)
Xingquan Zhao (ORCID: https://orcid.org/0000-0001-8345-5147)
Yongjun Wang (ORCID: https://orcid.org/0000-0002-9976-2341)
Yilong Wang (ORCID: https://orcid.org/0000-0002-3267-0039)
Ling Guan (ORCID: https://orcid.org/0000-0003-3381-8370)
Lei Wang (ORCID: https://orcid.org/0000-0002-1827-5470)
Shuya Li (ORCID: https://orcid.org/0000-0002-7263-0365)
Zhongrong Miao
Hui Qu

Institutions

Capital Medical University (CN)
Beijing Tian Tan Hospital (CN)
National Clinical Research Center for Digestive Diseases (CN)
National Institutes of Pharmaceutical Research and Development (China) (CN)
Chinese Institute for Brain Research (CN)
Beijing Anzhen Hospital (CN)

Publication Details

Journal: Stroke and Vascular Neurology
Published: 2025-04-17
DOI: https://doi.org/10.1136/svn-2024-003666
Primary Topic: Acute Ischemic Stroke Management
Type: article
Field-Weighted Citation Impact: 0.00

Funders

National Natural Science Foundation of China
National Science and Technology Major Project

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

E F fects of Y-6 S U blingual Tablets for Pa T ients with Ac U te Ischemic St R ok E (FUTURE): a phase II, randomised, double-blind, double-dummy, placebo-controlled, parallel trial

Y. Wang, Xiaoling Liao, Xiaochuan Huo, Yuesong Pan et al.

Apr 17, 2025

Stroke and Vascular Neurology

Acute Ischemic Stroke Management

article

E F fects of Y-6 S U blingual Tablets for Pa T ients with Ac U te Ischemic St R ok E (FUTURE): a phase II, randomised, double-blind, double-dummy, placebo-controlled, parallel trial

Y. Wang, Xiaoling Liao, Xiaochuan Huo, Yuesong Pan, Zixiao Li, Baoshan Qiu, Liping Liu, Xingquan Zhao, Yongjun Wang, Yilong Wang, Ling Guan, Lei Wang, Shuya Li, Zhongrong Miao, Hui Qu

April 17, 2025article en

Abstract

No abstract available for this paper.

Stroke and Vascular NeurologyVol. 10(6)

Capital Medical University (CN), Beijing Tian Tan Hospital (CN), National Clinical Research Center for Digestive Diseases (CN), National Institutes of Pharmaceutical Research and Development (China) (CN), Chinese Institute for Brain Research (CN), Beijing Anzhen Hospital (CN)

National Natural Science Foundation of China, National Science and Technology Major Project

Good health and well-being

Openalex Percentile: Top 88%

Acute Ischemic Stroke Management

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

E <b>F</b> fects of Y-6 S <b>U</b> blingual Tablets for Pa <b>T</b> ients with Ac <b>U</b> te Ischemic St <b>R</b> ok <b>E</b> (FUTURE): a phase II, randomised, double-blind, double-dummy, placebo-controlled, parallel trial — Y. Wang, Xiaoling Liao, et al. · Stroke and Vascular Neurology (2025) | TGRS Research Map | TGRS